References:
[1]. Aslanabadi
A, Ghabili K, Shad K, Khalili M, Sajadi MM. Emergence of whooping cough: notes
from three early epidemics in Persia. Lancet Infect Dis. 2015; 15 (12):1480-1484.
doi: 10.1016/S1473-3099(15)00292-3Torres J, Godoy P, Artigues A, et al.
[Outbreak of whooping cough with a high attack rate in well-vaccinated children
and adolescents]. Enferm Infecc Microbiol Clin. 2011; 29 (8):564-567.
doi:10.1016/j.eimc.2011.04.005.
[2]. Bettinger
JA, Halperin SA, De Serres G, Scheifele DW, Tam T. The effect of changing from
whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized
children with pertussis in Canada. Pediatr Infect Dis J. 2007; 26 (1):31-35.
doi:10.1097/01.inf.0000247055.81541.04.
[3]. Boughton
CR. Pertussis vaccines: acellular versus whole-cell. Med J Aust. 1996; 164 (9):564-566.
[4]. Bolotin
S, Harvill ET, Crowcroft NS. What to do about pertussis vaccines? Linking what
we know about pertussis vaccine effectiveness, immunology and disease
transmission to create a better vaccine. Pathog Dis. 2015;73 (8).
doi:10.1093/femspd/ftv057.
[5]. Choi
YH, Campbell H, Amirthalingam G, van Hoek AJ, Miller E. Investigating the
pertussis resurgence in England and Wales, and options for future control. BMC
Med. 2016; 14(1):121. doi: 10.1186/s12916-016-0665-8.
[6]. Crowcroft
NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of
pertussis? Lancet Infect Dis. 2003; 3(7):413-418.
[7]. Clark
TA. Changing Pertussis Epidemiology: Everything Old is New Again. J Infect Dis.
2014; 209(7):978-981. doi:10.1093/infdis/jiu001.
[8]. Eshofonie
AO, Lin H, Valcin RP, Martin LR, Grunenwald PE. An outbreak of pertussis in
rural Texas: an example of the resurgence of the disease in the United States.
J Community Health. 2015; 40(1):88-91. doi: 10.1007/s10900-014-9902-2.
[9]. Fedele
G, Bianco M, Debrie A-S, Locht C, Ausiello CM. Attenuated Bordetella pertussis
vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration
and drives a Th1/Th17 response. J Immunol Baltim Md 1950. 2011; 186(9):5388-5396.
doi:10.4049/jimmunol.1003765.
[10]. Forsyth
K, Nagai M, Lepetic A, Trindade E. Pertussis immunization in the global
pertussis initiative international region: recommended strategies and
implementation considerations. Pediatr Infect Dis J. 2005; 24 (5 Suppl):S93-97.
[11]. Gent
M van, Bart MJ, Heide HGJ van der, Heuvelman KJ, Mooi FR. Small Mutations in
Bordetella pertussis Are Associated with Selective Sweeps. PLOS ONE. 2012;
7(9):e46407. doi:10.1371/journal.pone.0046407.
[12]. Guo
B, Page A, Wang H, Taylor R, McIntyre P. Systematic review of reporting rates
of adverse events following immunization: an international comparison of
post-marketing surveillance programs with reference to China. Vaccine.
2013;31(4):603-617. doi:10.1016/j.vaccine.2012.11.051.
[13]. Gabutti
G, Rota MC. Pertussis: A Review of Disease Epidemiology Worldwide and in Italy.
Int J Environ Res Public Health. 2012; 9(12):4626-4638.
doi:10.3390/ijerph9124626.
[14]. Guiso
N. Bordetella pertussis and Pertussis Vaccines. Clin Infect Dis.
2009;49(10):1565-1569. doi: 10.1086/644733.
[15]. Gabutti
G, Azzari C, Bonanni P, et al. Pertussis. Hum Vaccines Immunother. 2014; 11(1):108-117.
doi:10.4161/hv.34364.
[16]. Gustafsson
L, Hessel L, Storsaeter J, Olin P. Long-term Follow-up of Swedish Children
Vaccinated With Acellular Pertussis Vaccines at 3, 5, and 12 Months of Age
Indicates the Need for a Booster Dose at 5 to 7 Years of Age. Pediatrics.
2006;118 (3):978-984. doi:10.1542/peds.2005-2746.
[17]. Heininger
U, Cherry JD, Christenson PD, et al. Comparative study of Lederle/Takeda
acellular and Lederle whole-cell pertussis-component
diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine. 1994; 12(1):81-86.
[18]. Hawken
S, Manuel DG, Deeks SL, Kwong JC, Crowcroft NS, Wilson K. Underestimating the
safety benefits of a new vaccine: the impact of acellular pertussis vaccine
versus whole-cell pertussis vaccine on health services utilization. Am J
Epidemiol. 2012; 176(11):1035-1042. doi:10.1093/aje/kws167.
[19]. Johri
AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and
vaccine development. Nat Rev Microbiol. 2006;4(12):932-942. doi: 10.1038/nrmicro1552.
[20]. Jongerius
I, Schuijt TJ, Mooi FR, Pinelli E. Complement evasion by Bordetella pertussis:
implications for improving current vaccines. J Mol Med Berl Ger. 2015; 93(4):395-402.
doi: 10.1007/s00109-015-1259-1.
[21]. Klein
NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative
Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers.
Pediatrics. May 2013:peds.2012-3836. doi:10.1542/peds.2012-3836.
[22]. Kline
JM, Lewis WD, Smith EA, Tracy LR, Moerschel SK. Pertussis: a reemerging
infection. Am Fam Physician. 2013; 88(8):507-514.
[23]. Kiedrzynski
T, Bissielo A, Suryaprakash M, Bandaranayake D. Whooping cough—where are we
now? A review. N Z Med J. 2015; 128(1416):21-27.
[24]. King
AJ, van Gorkom T, van der Heide HG, Advani A, van der Lee S. Changes in the
genomic content of circulating Bordetella pertussis strains isolated from the
Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC
Genomics. 2010; 11:64. doi: 10.1186/1471-2164-11-64.
[25]. Klein
NP, Bartlett J, Fireman B, et al. Waning protection following 5 doses of a
3-component diphtheria, tetanus, and acellular pertussis vaccine. Vaccine.
2017; 35 (26):3395-3400. doi:10.1016/j.vaccine.2017.05.008.
[26]. Ligon
BL. Pertussis: An historical review of the research and of the development of
whole-cell and acellular vaccines. Semin Pediatr Infect Dis. 1998; 9(2):168-178.
doi: 10.1016/S1045-1870(98)80068-X.
[27]. Liberia
battles whooping cough outbreak. Outbreak News Today. March 2015. http://outbreaknewstoday.com/liberia-battles-whooping-cough-outbreak-33731/.
Accessed February 10, 2018.
[28]. Leila
Denmark. In: Wikipedia. ; 2017. https://en.wikipedia.org/w/index.php?title=Leila_Denmark&oldid=812452583.
Accessed February 10, 2018.
[29]. Lin
J, Nishino K, Roberts MC, Tolmasky M, Aminov RI, Zhang L. Mechanisms of
antibiotic resistance. Front Microbiol. 2015;6. doi:10.3389/fmicb.2015.00034.
[30]. Lupo
A, Coyne S, Berendonk TU. Origin and Evolution of Antibiotic Resistance: The
Common Mechanisms of Emergence and Spread in Water Bodies. Front Microbiol.
2012; 3. doi:10.3389/fmicb.2012.00018.
[31]. Mnookin
S. The whole cell pertussis vaccine, media malpractice, and the long-term
effects of avoiding difficult conversations. Panic Virus. http://blogs.plos.org/thepanicvirus/2012/09/13/the-whole-cell-pertussis-vaccine-media-malpractice-and-the-long-term-effects-of-avoiding-difficult-conversations/.
Accessed February 10, 2018.
[32]. Miguez
Santiyan A, Ferrer Estrems R, Chover Lara JL, Alberola Enguidanos J, Nogueira
Coito JM, Salazar Cifre A. Early intervention in pertussis outbreak with high
attack rate in cohort of adolescents with complete acellular pertussis
vaccination in Valencia, Spain, April to May 2015. Euro Surveill Bull Eur Sur
Mal Transm Eur Commun Dis Bull. 2015; 20(27).
[33]. Nowlan
M, Turner N, Kiedrzynski T, Murfitt D, Sawicki N. Pertussis control strategies:
A consistent approach for New Zealand. Synopsis of Ministry of Health Workshop,
April 2015. N Z Med J. 2016; 129(1433):78-85.
[34]. Pertussis
| Whooping Cough | Causes and Transmission | CDC. https://www.cdc.gov/pertussis/about/causes-transmission.html.
Published August 18, 2017. Accessed February 10, 2018.
[35]. Pertussis
| Surveillance Trend Reporting and Case Definition | CDC. https://www.cdc.gov/pertussis/surv-reporting.html.
Published February 6, 2018. Accessed February 10, 2018.
[36]. Parton
R. Review of the biology of Bordetella pertussis. Biol J Int Assoc Biol Stand.
1999; 27(2):71-76. doi:10.1006/biol.1999.0182.
[37]. Pertuss-surv-report-2013.pdf.
https://www.cdc.gov/pertussis/downloads/pertuss-surv-report-2013.pdf. Accessed
February 10, 2018.
[38]. Pertussis
| Surveillance Trend Reporting and Case Definition | CDC. https://www.cdc.gov/pertussis/surv-reporting.html.
Published February 6, 2018. Accessed February 10, 2018.
[39]. Porras-Povedano
M, Roldán-Garrido A, Santacruz-Hamer V. [Outbreak of Whooping cough in
2016.Écija, Seville, Spain]. Rev Esp Salud Publica. 2017; 91.
[40]. Pertussis
Outbreak Among Vaccinated Preschoolers Raises Alarm. Medscape. http://www.medscape.com/viewarticle/857368.
Accessed February 10, 2018.
[41]. pertuss-surv-report-2012.pdf.
https://www.cdc.gov/pertussis/downloads/pertuss-surv-report-2012.pdf. Accessed
February 10, 2018.
[42]. Potin
M, Fica A, Véliz L, Moreno G, Wilhelm J, Cerda J. [Strategies to protect the
newborn and infants under 6 months of age against pertussis: Statement of the
Advisory Committee for Immunizations of the Chilean Infectious Diseases
Society]. Rev Chil Infectologia Organo of Soc Chil Infectologia. 2016; 33(5):543-546.
doi:10.4067/S0716-10182016000500009.
[43]. Pertussis
| Whooping Cough | Surveillance | Cases by Year | CDC. https://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html.
Published February 6, 2018. Accessed February 10, 2018.
[44]. Pichichero
ME, Green JL, Francis AB, Marsocci SM, Murphy AM, Buscarino C. Antibody
response and reactions to completion of a four-dose series with a two- or
three-component acellular pertussis vaccine compared to whole cell pertussis
vaccine. Scand J Infect Dis. 1996; 28(2):159-163.
[45]. Rendi-Wagner
P, Kundi M, Mikolasek A, Vécsei A, Frühwirth M, Kollaritsch H. Hospital-based
active surveillance of childhood pertussis in Austria from 1996 to 2003:
estimates of incidence and vaccine effectiveness of whole-cell and acellular
vaccine. Vaccine. 2006;24(33-34):5960-5965. doi:10.1016/j.vaccine.2006.05.011.
[46]. Schwartz
KL, Kwong JC, Deeks SL, et al. Effectiveness of pertussis vaccination and duration
of immunity. CMAJ Can Med Assoc J. 2016; 188(16):E399-E406.
doi:10.1503/cmaj.160193.
[47]. Shahcheraghi
F, Lotfi MN, Nikbin VS, et al. The First Macrolide-Resistant Bordetella
pertussis Strains Isolated From Iranian Patients. Jundishapur J Microbiol. 2014;7(6).
doi:10.5812/jjm.10880.
[48]. Simondon
F, Yam A, Gagnepain JY, Wassilak S, Danve B, Cadoz M. Comparative safety and
immunogenicity of an acellular versus whole-cell pertussis component of
diphtheria-tetanus-pertussis vaccines in Senegalese infants. Eur J Clin
Microbiol Infect Dis. 1996; 15(12):927-932. doi: 10.1007/BF01690510.
[49]. Sheridan
SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis
vaccines in infancy and disease protection. JAMA. 2012; 308(5):454-456. doi:10.1001/jama.2012.6364.
[50]. Souder
E, Long SS. Pertussis in the Era of New Strains of Bordetella pertussis. Infect
Dis Clin North Am. 2015;29(4):699-713. doi:10.1016/j.idc.2015.07.005.
[51]. WHO |
Pertussis. WHO. http://www.who.int/biologicals/vaccines/pertussis/en/. Accessed
February 10, 2018.
[52]. Wendelboe
AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis
after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5
Suppl):S58-61.
[53]. Wagner
B, Melzer H, Freymüller G, et al. Genetic Variation of Bordetella pertussis in
Austria. PLOS ONE. 2015;10(7):e0132623. doi:10.1371/journal.pone.0132623.
[54]. Xu Y,
Wang Y, Tan Y, et al. Production and characterization of recombinant pertactin,
fimbriae 2 and fimbriae 3 from Bordetella pertussis. BMC Microbiol. 2009; 9:274.
doi: 10.1186/1471-2180-9-274.
[55]. Zhang
L, Prietsch SOM, Axelsson I, Halperin SA. Acellular vaccines for preventing
whooping cough in children. Cochrane Database Syst Rev. 2014; (9):CD001478.
doi:10.1002/14651858.CD001478.pub6.
[56]. Yeung
KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of
pertussis in children younger than 5 years: a modelling study. Lancet Infect
Dis. 2017;17(9):974-980. doi: 10.1016/S1473-3099(17)30390-0.
[57]. 11_YZhang.pdf.
http://www.moleculartb.org/gb/pdf/transcriptions/11_YZhang.pdf. Accessed
February 10, 2018.
[58]. 11_YZhang.pdf.
http://www.moleculartb.org/gb/pdf/transcriptions/11_YZhang.pdf. Accessed
February 11, 2018.
[59]. Zhang
L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing
whooping cough in children. Cochrane Database Syst Rev. 2011; (1):CD001478.
doi:10.1002/14651858.CD001478.pub4.